Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Discovery of self-synergistic spinal/supraspinal antinociception produced by acetaminophen (paracetamol)
457 The basket trial of KY100001K uses IDH mutation as the core enrollment criterion, overcoming tumor tissue-of-origin constraints to efficiently evaluate its efficacy and safety across multiple cancer types, thereby accelerating the precise development of rare molecular subtypes and providing a rationale for pancancer applications
The epigenetic landscape of T cell exhaustion
This mutant is resistant to cleavage by matriptase but sensitive to PAR2 activation by FXa-like proteases (31)
US$ 24.49
US$ 19.98
US$ 24.39
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
